share_log

Avalon Holdings | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Avalon Holdings | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Avalon控股 | SC 13D/A:超過5%持股股東披露文件(修正)
美股SEC公告 ·  08/16 07:03

Moomoo AI 已提取核心訊息

On August 16th, 2024, Dr. Anil Choudary Nalluri, a psychiatrist based in Ohio, filed an amendment to the Schedule 13D with the United States Securities and Exchange Commission, disclosing his beneficial ownership of over 20% of Avalon Holdings Corporation's Class A Common Stock. Dr. Nalluri now owns 1,092,356 shares, representing approximately 33.226% of the company's outstanding shares. The filing indicates that these shares were acquired using personal funds and that Dr. Nalluri has sole voting and dispositive power over these shares. While Dr. Nalluri has not outlined any specific plans or proposals for the company, he reserves the right to change his investment strategy, which may include buying more shares, selling his stake, or formulating plans regarding the company's securities. The filing emphasizes that Dr. Nalluri's actions will be aimed at maximizing the value of his investments, taking into account market conditions and the business prospects of Avalon Holdings.
On August 16th, 2024, Dr. Anil Choudary Nalluri, a psychiatrist based in Ohio, filed an amendment to the Schedule 13D with the United States Securities and Exchange Commission, disclosing his beneficial ownership of over 20% of Avalon Holdings Corporation's Class A Common Stock. Dr. Nalluri now owns 1,092,356 shares, representing approximately 33.226% of the company's outstanding shares. The filing indicates that these shares were acquired using personal funds and that Dr. Nalluri has sole voting and dispositive power over these shares. While Dr. Nalluri has not outlined any specific plans or proposals for the company, he reserves the right to change his investment strategy, which may include buying more shares, selling his stake, or formulating plans regarding the company's securities. The filing emphasizes that Dr. Nalluri's actions will be aimed at maximizing the value of his investments, taking into account market conditions and the business prospects of Avalon Holdings.
2024年8月16日,位於俄亥俄州的精神科醫生Anil Choudary Nalluri博士向美國證監會提交了修改後的13D表格,披露他持有Avalon控股公司A類普通股超過20%的權益。Nalluri博士現在擁有1,092,356股,佔該公司流通股約33.226%。該文件表明,這些股票是使用個人資金購買的,Nalluri博士對這些股票享有獨立的投票和決策權。儘管Nalluri博士沒有爲該公司制定任何具體計劃或建議,但他保留改變自己的投資策略的權利,這可能包括購買更多的股票、出售他的股份或制定關於該公司證券的計劃。該文件強調,Nalluri博士的行動將旨在最大化他的投資價值,同時考慮到市場條件和Avalon控股的業務前景。
2024年8月16日,位於俄亥俄州的精神科醫生Anil Choudary Nalluri博士向美國證監會提交了修改後的13D表格,披露他持有Avalon控股公司A類普通股超過20%的權益。Nalluri博士現在擁有1,092,356股,佔該公司流通股約33.226%。該文件表明,這些股票是使用個人資金購買的,Nalluri博士對這些股票享有獨立的投票和決策權。儘管Nalluri博士沒有爲該公司制定任何具體計劃或建議,但他保留改變自己的投資策略的權利,這可能包括購買更多的股票、出售他的股份或制定關於該公司證券的計劃。該文件強調,Nalluri博士的行動將旨在最大化他的投資價值,同時考慮到市場條件和Avalon控股的業務前景。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息